Skip to main content

Table 7 Complications of the ERAS and control groups

From: Analgesia and patient comfort after enhanced recovery after surgery in uvulopalatopharyngoplasty: a randomised controlled pilot study

 

ERAS Group

(n = 65)

Control Group

(n = 39)

P value

Total complication(n(%))

6(9.23%)

3(7.69%)

0.787

Wound bleeding(n(%))

4(6.15%)

2(5.13%)

0.828

 Primary bleeding

2(3.08%)

1(2.56%)

0.880

 Secondary bleeding

2(3.08%)

1(2.56%)

0.880

Gastrointestinal Haemorrhage(n(%))

1(1.54%)

0(0%)

0.436

Hypoxia(n(%))

1(1.54%)

0(0%)

0.436

Wound infection(n(%))

0(0%)

1(2.56%)

0.195

  1. ERAS Enhanced recovery after surgery